Description

Co-Amoxiclav Dispersible Tablets BP

Noirclav 228.5 Tablets are broad-spectrum antibiotics designed to treat a variety of bacterial infections. The combination of Amoxicillin, a penicillin-class antibiotic, and Clavulanic Acid, a beta-lactamase inhibitor, enhances antibacterial activity and helps overcome resistance in beta-lactamase-producing bacteria.

Amoxicillin inhibits bacterial cell wall synthesis, leading to cell lysis and bacterial death.

Clavulanic Acid inhibits beta-lactamase enzymes produced by resistant bacteria, restoring the efficacy of Amoxicillin.

Indications / Benefits:

Respiratory Tract Infections – Effective for bronchitis, pneumonia, sinusitis, and tonsillitis.

Urinary Tract Infections (UTIs) – Treats cystitis, pyelonephritis, and other urinary infections.

Skin and Soft Tissue Infections – Useful for cellulitis, abscesses, and wound infections.

Ear, Nose, and Throat (ENT) Infections – Effective in treating otitis media, pharyngitis, and sinus infections.

Convenient Dispersible Form – Easily dissolved in water for patients who have difficulty swallowing tablets.

Broad-Spectrum Activity – Provides effective treatment against a wide range of susceptible bacterial infections.